|
Real-time Estimate
Cboe BZX
08:07:05 30/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.885 USD | +0.80% |
|
-6.19% | +21.47% |
| 16/09 | Novartis halts ALS drug development after mid-stage trial failure | RE |
| 15/09 | Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.80% | -6.19% | -16.15% | -5.72% | +21.47% | -35.98% | -69.39% | -91.70% | - | 21Cr | |
| -0.70% | -4.28% | +2.07% | +27.34% | +77.25% | +52.62% | +86.42% | +7.04% | - | 7.15TCr | |
| -0.78% | +0.74% | -3.84% | +3.77% | +17.47% | +36.42% | +80.30% | +224.47% | +5,403.27% | 6.01TCr | |
| -1.27% | +2.53% | -0.10% | +5.53% | +7.10% | +9.26% | +36.98% | -17.90% | +210.34% | 4.89TCr | |
| +0.65% | +1.02% | +3.60% | +40.04% | +20.04% | +42.46% | +39.57% | +12.96% | +233.81% | 4.43TCr | |
| +0.81% | +8.01% | +0.22% | +10.01% | +158.66% | +341.17% | +687.26% | +648.91% | - | 4.38TCr | |
| +1.78% | +1.56% | +3.09% | +30.08% | +22.02% | +8.80% | +107.67% | +2.12% | +1,103.16% | 4.15TCr | |
| +0.34% | +0.22% | -6.19% | -0.17% | +3.78% | +5.18% | +47.36% | -16.63% | +135.73% | 3.01TCr | |
| +4.77% | +6.16% | +14.76% | +61.99% | +78.28% | +36.77% | +26.10% | -55.69% | - | 2.8TCr | |
| -1.35% | -3.45% | -6.21% | +7.17% | -34.35% | -20.66% | +350.37% | +314.89% | +686.91% | 2.53TCr | |
| -0.99% | -0.57% | -3.65% | +5.21% | +2.84% | -0.73% | -13.17% | -64.14% | - | 2.48TCr | |
| +1.62% | +2.05% | +10.23% | +30.31% | +15.39% | +21.35% | -4.30% | -16.73% | +106.99% | 2.1TCr | |
| -0.44% | -0.20% | +3.69% | +16.30% | +9.66% | +19.79% | +153.92% | +225.40% | +1,962.68% | 1.74TCr | |
| +3.46% | +3.02% | -22.65% | +4.38% | +182.04% | +158.90% | +337.81% | +1,394.96% | +639.22% | 1.55TCr | |
| -0.97% | -0.89% | +4.05% | +10.09% | +20.96% | +22.18% | +44.21% | -31.90% | +86.67% | 1.5TCr | |
| -0.21% | +2.06% | -13.42% | -14.62% | - | - | - | - | - | 1.5TCr | |
| +1.09% | +9.73% | +33.29% | +45.07% | +42.32% | +4.13% | - | - | - | 1.49TCr | |
| +0.97% | +4.09% | +8.07% | +8.53% | +34.73% | +42.98% | +165.75% | +179.33% | +361.69% | 1.45TCr | |
| +2.96% | +0.83% | -2.05% | +11.65% | +24.17% | -5.25% | +519.59% | - | - | 1.44TCr | |
| -0.21% | +6.86% | +2.82% | +30.68% | +48.57% | +89.42% | +53.24% | -28.18% | +255.60% | 1.41TCr | |
| Average | +0.64% | -0.24% | +0.58% | +16.38% | +39.60% | +43.62% | +147.21% | +158.07% | +932.17% | 2.8TCr | |
| Weighted average by Cap. | +0.38% | -0.07% | +1.06% | +18.33% | +42.17% | +54.48% | +148.88% | +142.40% | +1,349.30% |
- Stock Market
- Stocks
- ALEC Stock
- Sector Alector, Inc.
Select your edition
All financial news and data tailored to specific country editions
